“Efficacy and Safety of Biosimilar Cetuximab (CETUXA) in Locoregionally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck: A Retrospective Multicenter Analysis.”. Journal of Carcinogenesis 24, no. 10s (December 1, 2025): 382–389. Accessed December 26, 2025. https://carcinogenesis.com/index.php/JOC/article/view/1662.